Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like 13 Uranium Companies Exploring Canada’s Athabasca Basin July 1, 2025 Germany, Italy Face Pressure to Repatriate US$245 Billion... June 25, 2025 NVIDIA Rallies After Strong Q1, AI Demand Outshines... May 31, 2025 Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin... April 26, 2025 Quimbaya Gold Announces Termination of LOI with Denarius... August 2, 2025 Crypto Market Update: Ethereum Funds Draw US$2.12 Billion... July 22, 2025 SAGA Metals Appoints Vernon Shein, Former Exploration Manager... May 15, 2025 Editor’s Picks: Gold Tariff Threat Ends, Price Reacts... August 16, 2025 Prismo Engages Windfall Geotek for Data Analysis at... August 18, 2025 Guide to Uranium Mining in Canada August 21, 2025